Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | Director | February 06, 2024 | February 09, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date February 06, 2024 · Filed February 09, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,057 |
Reported balance
After 2024-02-06 transaction · row 1
1 source rowRow 1 · 2024-02-06 · Grant · Acquired 5,815 · Balance 31,057 F1: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2024 Filed Feb 9, 2024 21:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 5,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-002248 · marketforms-64640.xml · nonDerivative · entry 1 Mai Xiaoying · CIK 0001754806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,057 F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 21:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 8,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-001877 · marketforms-59387.xml · nonDerivative · entry 1 Mai Xiaoying · CIK 0001754806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,242 F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 22:00 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 3,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-002203 · marketforms-55361.xml · nonDerivative · entry 1 Mai Xiaoying · CIK 0001754806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,030 F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 973 | $0.00 Strike: $189.96 | $0.00 |
DisclosureSEC source: 0001214659-22-002109 · marketforms-55339.xml · derivative · entry 4 Mai Xiaoying · CIK 0001754806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 973 Underlying: Common Stock · 973 shares Expires 2031-02-02 F1 · derivative.exercise_date: Each equity is fully vested at the time of grant, but represent equity awards for prior annual meetings in 2019, 2020 and 2021 that the Company was not able to grant. If the grants had been made at the time of the prior annual meetings, each grant would have vested upon the earlier of (1) the 1 year anniversary of the date of grant or (2) the next annual meeting. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 11,297 | $0.00 Strike: $60.33 | $0.00 |
DisclosureSEC source: 0001214659-22-002109 · marketforms-55339.xml · derivative · entry 3 Mai Xiaoying · CIK 0001754806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,297 Underlying: Common Stock · 11,297 shares Expires 2030-02-03 F1 · derivative.exercise_date: Each equity is fully vested at the time of grant, but represent equity awards for prior annual meetings in 2019, 2020 and 2021 that the Company was not able to grant. If the grants had been made at the time of the prior annual meetings, each grant would have vested upon the earlier of (1) the 1 year anniversary of the date of grant or (2) the next annual meeting. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantDirector Stock Option (right to buy) · Derivative | 10,588 | $0.00 Strike: $60.33 | $0.00 |
DisclosureSEC source: 0001214659-22-002109 · marketforms-55339.xml · derivative · entry 2 Mai Xiaoying · CIK 0001754806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,588 Underlying: Common Stock · 10,588 shares Expires 2029-07-22 F1 · derivative.exercise_date: Each equity is fully vested at the time of grant, but represent equity awards for prior annual meetings in 2019, 2020 and 2021 that the Company was not able to grant. If the grants had been made at the time of the prior annual meetings, each grant would have vested upon the earlier of (1) the 1 year anniversary of the date of grant or (2) the next annual meeting. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 13,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-002109 · marketforms-55339.xml · nonDerivative · entry 1 Mai Xiaoying · CIK 0001754806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,539 F1 · shares: Each equity is fully vested at the time of grant, but represent equity awards for prior annual meetings in 2019, 2020 and 2021 that the Company was not able to grant. If the grants had been made at the time of the prior annual meetings, each grant would have vested upon the earlier of (1) the 1 year anniversary of the date of grant or (2) the next annual meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.